Abstract
When injected i.v. into mice, the F10 subline of B16 melanoma cells produced significantly more lung tumours over a 3-week period than cells of the F101.r-6 subline. However, in animals bearing intramuscular tumours produced by these sublines, the high pulmonary-colonization potential of the F10 cells was not realized, and no significant differences in natural pulmonary metastasis formation were observed in animals with untreated primary cancers, even when they progressed to the moribund state. Massage of i.m. tumours derived from the two sublines produced no change in metastasis and no changes in the numbers of cancer cells in the blood detectable by bioassay. In contrast, massage increased metastasis from tumours derived from an invasive BL6 subline and B16 wild-type cells and, in the case of the wild-type, the numbers of circulating cancer cells. In vitro experiments show that blood cells from non-tumour-bearing animals are toxic to both sublines; but less to F10 than to F101.r-6. In addition, after i.v. injection of radiolabelled cells, more of the F10 subline were retained in the lungs of recipients than the F101.r-6. In spite of these apparent metastatic advantages of the F10 subline following intravasation, the incidence of natural metastases from i.m. F10 and F101.r-6 tumours was similar, suggesting that substantially fewer F10 than F101.r-6 cells gained access to the circulation. Thus, the higher colonization potential of the F10 cells was not matched by its intravasation potential, since metastatic efficiency is determined by the least efficient step in the metastatic process.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crile G., Jr, Isbister W., Deodhar S. D. Lack of correlation between the presence of circulating tumor cells and the development of pulmonary metastases. Cancer. 1971 Sep;28(3):655–656. doi: 10.1002/1097-0142(197109)28:3<655::aid-cncr2820280318>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- Fidler I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 1975 Jan;35(1):218–224. [PubMed] [Google Scholar]
- Fidler I. J., Gersten D. M., Budmen M. B. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 1976 Sep;36(9 PT1):3160–3165. [PubMed] [Google Scholar]
- Fidler I. J. Selection of successive tumour lines for metastasis. Nat New Biol. 1973 Apr 4;242(118):148–149. doi: 10.1038/newbio242148a0. [DOI] [PubMed] [Google Scholar]
- Hart I. R. The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol. 1979 Dec;97(3):587–600. [PMC free article] [PubMed] [Google Scholar]
- Hofer K. G., Prensky W., Hughes W. L. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer Inst. 1969 Oct;43(4):763–773. [PubMed] [Google Scholar]
- Hoover H. C., Jr, Ketcham A. S. Techniques for inhibiting tumor metastases. Cancer. 1975 Jan;35(1):5–14. doi: 10.1002/1097-0142(197501)35:1<5::aid-cncr2820350103>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- Poste G., Doll J., Hart I. R., Fidler I. J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 1980 May;40(5):1636–1644. [PubMed] [Google Scholar]
- Wang B. S., McLoughlin G. A., Richie J. P., Mannick J. A. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res. 1980 Feb;40(2):288–292. [PubMed] [Google Scholar]
- Weiss L., Glaves D., Waite D. A. The influence of host immunity on the arrest of circulating cancer cells, and its modification by neuraminidase. Int J Cancer. 1974 Jun 15;13(6):850–862. doi: 10.1002/ijc.2910130612. [DOI] [PubMed] [Google Scholar]
- ZEIDMAN I., McCUTCHEON M., COMAN D. R. Factors affecting the number of tumor metastases; experiments with a transplantable mouse tumor. Cancer Res. 1950 Jun;10(6):357–359. [PubMed] [Google Scholar]